Table 5.6e

Immunosuppression Use for Maintenance

Prior to Discharge, 1996 to 2005

Recipients with Kidney Transplants

  Year of Transplant
1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
Functioning Graft at Discharge 10,889 11,241 11,999 12,274 13,103 13,812 14,323 14,689 15,535 16,005
With Immunosuppression Info 10,687 11,195 11,931 12,089 12,886 13,788 14,260 14,614 15,402 15,523
Corticosteroids Any in Category 97.1% 97.4% 96.6% 97.3% 95.7% 93.6% 91.1% 84.7% 77.2% 73.5%
Steroids 97.1% 97.4% 96.6% 97.3% 95.7% 93.6% 91.1% 84.7% 77.2% 73.5%
Cyclosporine Any in Category 75.8% 76.5% 67.7% 61.5% 51.1% 37.5% 29.8% 25.9% 21.1% 14.9%
Cyclosporin 8.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1%
Sandimmmune 11.6% 7.4% 5.4% 5.3% 3.1% 2.5% 1.4% 0.9% 0.7% 0.5%
Neoral 55.8% 69.1% 62.2% 55.9% 47.0% 30.2% 21.7% 19.2% 14.4% 9.7%
Gengraf 0.0% 0.0% 0.0% 0.2% 0.9% 4.7% 6.5% 5.7% 5.8% 4.5%
Eon 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.2% 0.1% 0.1% 0.1%
Tacrolimus Any in Category 12.5% 18.7% 26.4% 32.9% 44.1% 56.4% 63.8% 66.8% 71.9% 78.7%
Tacrolimus 12.5% 18.7% 26.4% 32.9% 44.1% 56.4% 63.8% 66.8% 71.9% 78.7%
Antimetabolites Any in Category 80.5% 86.4% 85.2% 86.3% 80.3% 79.7% 82.1% 82.8% 83.6% 87.5%
Mycophenolate Mofetil 48.5% 66.3% 72.9% 78.1% 74.8% 75.5% 79.3% 80.4% 80.7% 81.8%
Mycophenolate Sodium 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.4% 0.5% 1.6% 5.1%
Azathioprine 31.8% 20.0% 12.1% 7.9% 5.3% 4.1% 2.3% 1.8% 1.3% 0.6%
Leflunomide 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Cytoxan 0.2% 0.2% 0.1% 0.2% 0.2% 0.1% 0.1% 0.0% 0.0% 0.0%
mTOR Inhibitors Any in Category 1.5% 3.3% 3.2% 3.0% 13.2% 17.3% 15.5% 15.7% 12.6% 9.4%
Sirolimus 1.5% 3.3% 3.0% 2.5% 13.0% 17.2% 14.9% 15.7% 12.4% 9.1%
Everolimus 0.0% 0.0% 0.2% 0.4% 0.2% 0.1% 0.6% 0.0% 0.2% 0.3%


Source: OPTN/SRTR Data as of May 1, 2006.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients maybe prescribed more than one drug within the same category.